RIMADYL PALATABLE TABLETS 50 MG
Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
Résumé des caractéristiques du produit
(SPC)
06-06-2024
Certains documents pour ce produit ne sont pas disponibles actuellement, vous pouvez envoyer une demande à notre service client et nous vous informerons dès que nous pourrons les obtenir.
Envoyer une demande.
Envoyer une demande.
Ingrédients actifs:
CARPROFEN
Disponible depuis:
Pfizer Healthcare Ireland
Code ATC:
QM01AE91
Dosage:
50 mg/tablet
forme pharmaceutique:
Tablets
Groupe thérapeutique:
N.S.A.I.D
Domaine thérapeutique:
Canine
Date de l'autorisation:
2004-03-19
Résumé des caractéristiques du produit
IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA: 10019/079/002
Case No: 7006084
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
PFIZER HEALTHCARE IRELAND
TRADING AS PFIZER ANIMAL HEALTH, RINGASKIDDY, CO. CORK, IRELAND
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
RIMADYL PALATABLE TABLETS 50 MG
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in the said Schedule.
The authorisation,unless revoked, shall continue in force from 09/09/2009.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 11/09/2009_
_CRN 7006084_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Rimadyl Palatable Tablets 50 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 50 mg Carprofen.
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Chewable tablets.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For analgesia and reduction of chronic inflammation, for example in degenerative joint disease, in the dog.
Rimadyl Palatable Tablets can also be used
Lire le document complet
